WinstonWınston
PetVivo Holdings logo

PetVivo Holdings

PETV
31
Medical - Devices · Healthcare
Price
$0.77
+0.00 (+0.26%)
Market Cap
$23.1M
Winston Score
31
Winston is serious
Below-average fundamentals — multiple weak pillars.

Share count rising — dilution

+244.2% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 8.8M (2022) → 30.2M (2026)

PetVivo Holdings is a small medical device company that makes treatments for animals, mainly pets like dogs and cats. Its main product is Spryng, an injectable device that helps relieve joint pain in animals without surgery. The company sells to veterinarians, who then use the product to treat pets suffering from osteoarthritis.

PetVivo earns money by selling its Spryng product directly to veterinary clinics across the United States. The company is very small, with a market cap near zero, and is not yet profitable — its operating losses are far larger than its revenue. The core risk is that the company is burning through cash while trying to build awareness and adoption among vets, and it will likely need to raise more money to keep operating.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+365.6% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+36.8% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$1M/ year

Declining (-11% vs prior year)

124.0% of revenue

6.9x the sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

42.9%ownership

Rising

Insiders increasing their stake — aligned with shareholders

Cash Runway

~0 months

$227,689 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Revenue accelerating

PetVivo Holdings grew revenue 366% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
81.3%
Premium pricing power — 81.3% gross margin
Operating Margin
-925.4%
Losing money on operations — -925.4%
ROCE
-33.8%
Weak — -33.8% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+16.3%
Fast-growing sales (16.3% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-635.5%
Burning cash (-635.5%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.46
Conservative — low debt load (0.46)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial